Related Experiment Video
Updated: Jun 5, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies
Eva A Operskalski1, Andrea Kovacs
1Maternal Child and Adolescent Center for Infectious Diseases and Virology, Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, 90033, USA. eva@usc.edu
Insights
Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection significantly impacts liver disease progression. New research reviews pathogenesis, co-infection effects, and updated treatment strategies for HIV/HCV.
Area of Science:
- Hepatology and Virology
- Immunology
- Infectious Diseases
Background:
- Hepatitis C virus (HCV) affects 130 million globally, with 3-5 million coinfected with HIV.
- HIV accelerates HCV progression, leading to liver disease and death.
- HCV's impact on HIV progression remains debated, but HCV-related diseases are key concerns in coinfected individuals on antiretroviral therapy.
Purpose of the Study:
- To review current research on HIV/HCV coinfection pathogenesis.
- To analyze the effects of coinfection on HIV disease, liver health, immune function, and other organ systems.
- To evaluate current and novel therapeutic strategies for HIV and HCV in coinfected patients.
Main Methods:
- Comprehensive literature review of recent studies.
- Analysis of pathogenesis, clinical outcomes, and treatment efficacy.
- Synthesis of data on viral interactions and host responses.
Main Results:
- HIV negatively impacts HCV natural history, increasing viral load and fibrosis.
- HCV's effect on HIV progression is under investigation, though survival has improved with antiretroviral therapy.
- HCV-associated liver disease is a major comorbidity in coinfected individuals.
Conclusions:
- HIV/HCV coinfection presents complex challenges requiring integrated management.
- Further research is needed to fully understand HCV's impact on HIV and to optimize treatment strategies.
- Effective antiretroviral therapy has improved survival, highlighting the importance of managing HCV-related complications.
Abstract:
World-wide, hepatitis C virus (HCV) accounts for approximately 130 million chronic infections, with an overall 3% prevalence. Four to 5 million persons are co-infected with HIV. It is well established that HIV has a negative impact on the natural history of HCV, including a higher rate of viral persistence, increased viral load, and more rapid progression to fibrosis, end-stage liver disease, and death. Whether HCV has a negative impact on HIV disease progression continues to be debated. However, following the introduction of effective combination antiretroviral therapy, the survival of coinfected individuals has significantly improved and HCV-associated diseases have emerged as the most important co-morbidities. In this review, we summarize the newest studies regarding the pathogenesis of HIV/HCV coinfection, including effects of coinfection on HIV disease progression, HCV-associated liver disease, the immune system, kidney and cardiovascular disease, and neurologic status; and effectiveness of current anti-HIV and HCV therapies and proposed new treatment strategies.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
Sexually Transmitted Infections

